Search Results for: MANAGEMENT INSIGHT Pharmaceutical Innovation in
Articles
SPECIAL FEATURE - Injection Devices: As Self-Injection Grows, Drug Delivery Gets Smarter August 28, 2018
Contributor Cindy H. Dubin reviews some of the innovative and novel technologies developers are deploying to make self-injection easier and improve patient adherence.
Saama Launches Deep Learning Intelligent Assistant (DaLIA) to Solve Clinical Development Pain Points June 21, 2018
Saama Technologies, Inc. recently announced the launch of a unique set of Artificial Intelligence (AI) capabilities specifically designed to alleviate...SPECIAL FEATURE - Outsourcing Formulation Development & Manufacturing: CDMOs Are Innovating for 21st-Century Medicine June 6, 2018
Contributor Cindy H. Dubin speaks with some of the industry’s leading CDMOs about the innovations they are developing for next-generation patient care, and how many are making investments that are enabling them to offer more services under one roof.
CLINICAL TRIALS - Why Are Metrics Important in Starting Clinical Trials? January 8, 2018
Craig Morgan believes metrics are indeed critical to efforts to rein in clinical trials that are either poorly initiated or have incurred unforeseen events, which place the original timelines and/or budgets at risk of overages.
Piramal Pharma Solutions Announces Large-Scale Expansion of API Manufacturing Facilities October 17, 2017
Piramal Pharma Solutions Announces Large-Scale Expansion of API Manufacturing Facilities Piramal Pharma Solutions (PPS), a leading Contract Development and Manufacturing...GENE & CELL THERAPY - Its Growing Potential to Disrupt Drug Research & Healthcare Delivery October 2, 2017
Jeff Galvin believes as the pace of gene and cell therapies accelerates over this next decade, potential cures for chronic diseases, cancer cures, and autosomal defect cures will result, and the efficacy of new therapeutics may move as much as $500 billion from traditional pharmaceuticals to gene technologies.
Roivant Sciences Launches Datavant to Improve Clinical Trials With Artificial Intelligence September 20, 2017
Roivant Sciences recently announced the launch of Datavant, a new company focused on employing artificial intelligence to improve the clinical...SPECIAL FEATURE - Injectable Drug Delivery: New Technologies Deliver Biologics & Differentiate Brands September 12, 2017
Contributor Cindy H. Dubin reports on a segment of the drug delivery industry that will see its market revenue double in just 5 years in response to a growing need to deliver highly viscous, high-volume drugs.
SPECIAL FEATURE - Prefilled Syringes & Parenteral Manufacturing: A Rise in Biologics & Improved Technology Give Pharma Reasons to Consider Parenteral Delivery May 2, 2017
Contributor Cindy H. Dubin speaks with some of the leading companies in this market to find out about key trends, packaging advancements, safety improvements, and technology developments.
CLINICAL RESEARCH - Behind the Wave: Clinical Research in a Digital Transformation Era May 1, 2017
Kai Langel believes the remote research model and purpose-built technology offer the tools and the right process to help modernize clinical research and bring it closer to the high standard set by today’s consumer technologies.
Permira Funds to Acquire Leading CDMO Lyophilization Services of New England April 3, 2017
Permira, the global private equity firm, recently announced that a company backed by the Permira funds has signed a definitive...West Introduces LyoSeal® Instant Sealing Solution & NovaGuard® SA Pro Safety System February 1, 2017
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently introduced two new offerings at...West Introduces LyoSeal® Instant Sealing Solution & NovaGuard® SA Pro Safety System February 1, 2017
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, recently introduced two new offerings at...COMBINATION PRODUCTS - 6 Guidelines to Follow When Developing Combination Products January 13, 2017
Winston Brown explains how companies can reduce the risk and impact that regulatory uncertainty can play by, in advance of pursuing development, understanding the regulatory landscape and then developing a regulatory compliance strategy that is appropriate and suitable for the combination product as a system.
EXECUTIVE INTERVIEW - Insulet Corporation: Improving Adherence Through Wearable, Patient-Centric Drug Delivery November 7, 2016
Michael Graffeo, Vice President of Business Development, Insulet Delivery Systems Group, discusses the importance of optimizing patient adherence to ensure improved clinical outcomes.
Inovalon & MDLIVE Bring Real-Time Advanced Analytics to Telemedicine Marketplace September 18, 2016
Inovalon recently announced a multi-year agreement with MDLIVE, a leading telehealth platform provider, to provide on-demand, real-time patient insights and...SPECIAL FEATURE - Prefilled Syringes & Parenteral Contract Manufacturing: Biologics Present a New Set of Challenges May 2, 2016
Contributor Cindy H. Dubin speaks with leading syringe developers and contract manufacturers to discuss how they are overcoming industry challenges and provides a look at some of the innovative advancements in prefilled syringe technology.
EXECUTIVE INTERVIEW - Terumo: Innovating at the Speed of Life for Cutting-Edge Solutions in Medical Devices & Services August 31, 2015
Mr. Juichi “Jim” Takeuchi, Terumo Corporation’s Executive Officer and President of Global Pharmaceutical Solutions, discusses his company’s innovative approach to parenteral drug delivery using integrated science and technology.
The CDMO Market: Implications of Patheon's IPO June 10, 2015
By: Patricia Van Arnum, DCAT Editorial Director, posted Tue, Jun 09, 2015 04:42 AM Patheon's announcement this week that it plans to...MARKET BRIEF - Miniaturizing Healthcare - From Microelectronics to Nanobiosensing March 3, 2015
Cecilia Van Cauwenberghe, MS, Technical Insights Senior Research Analyst, Frost & Sullivan, reports that the proliferation of lower cost microfluidics-based genomics tools offering improved capabilities and allowing more access to end-users is expected to drive this technology for pharmaceutical and biomedical research throughout the next 5 years.
